MimeCure is an innovative pharmaceutical start-up based on pioneering research conducted at the Groningen Research Institute of Pharmacy at the University of Groningen (NL). The discovery of molecules with potential therapeutic effects on COPD is the culmination of several years of intensive research at the university. Thanks to close collaboration between leading scientists from different disciplines, the research team has made significant progress in the development of new drugs for COPD.
Their work has led to an efficient research pipeline, from preclinical screening technologies to advanced formulation of bio-inspired molecules. Recognising the potential of these discoveries, they decided to separate from the university and founded MimeCure in April 2024 to transform these innovations into clinical solutions for COPD patients.
These cookies make sure the website functions properly. These cookies also provide us to anonymously monitor website statistics. Because these cookies are essential for the website, you can not disable them without compromising the functionality of the website.
These cookies collect data that we use to understand how our website is used and perceived. These cookies also help us to optimize the website for the best user experience.
These cookies allow ad-networks to monitor your online behaviour so they can display relevant ads based on your interest and online behaviour. These cookies also prevent the same ads from being displayed over and over.
